Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis
Overview
Changes in volumetric hemodynamic parameters and fluid overload (Cardiac Index,Stroke Volume, Thoracic Fluid Content, Systemic Vascular Resistance) were measured using a impedance cardiography (ICG) (CardioScreen 1000 – Haemodynamic Measurement System, Medis. GmbH Ilmenau) beginning 15 min prior to midweek dialysis session and continuous measurement thereafter, with a 15-min period after the termination of hemodialysis. Fluid overload were measured by BCM Monitor Fresenius before hemodialysis.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: September 2015
Interventions
- Device: CardioScreen 1000 – Haemodynamic Measurement System, Medis
- Impedance cardiography (ICG)
- Device: BCM- Body Composition Monitor, Fresenius Medical Care
- Information about the individual fluid status and the nutritional status.
- Device: SCHILLER, BR-102 plus, Ambulatory Blood Pressure Monitoring System
- Blood pressure monitoring every 15 min during hemodialysis
Arms, Groups and Cohorts
- Hemodialysis patients
- midweek dialysis session patients on maintenance hemodialysis at least 3 months stable dry weight single-pool Kt/V >1.4 no clinical cardiovascular disease during the 6 months preceding entry
Clinical Trial Outcome Measures
Primary Measures
- Changes in volumetric hemodynamic parameter- cardiac index [l/min/m2]) induced by fluid removal on hemodialysis.
- Time Frame: 1 day
Secondary Measures
- Changes in volumetric hemodynamic parameter- stroke volume [ml] induced by fluid removal on hemodialysis.
- Time Frame: 1 day
- Changes in volumetric hemodynamic parameter- systemic vascular resistance [dyn·s·cm-5] induced by fluid removal on hemodialysis.
- Time Frame: 1 day
- Changes in fluid removal parameter- thoracic fluid content [1/kOhm] during hemodialysis.
- Time Frame: 1 day
- Changes in blood pressure values [mmHg] induced by fluid removal on hemodialysis.
- Time Frame: 1 day
Participating in This Clinical Trial
Inclusion Criteria
- give voluntary consent to participate in the study – patients on maintenance hemodialysis at least 3 months – stable dry weight – single-pool Kt/V >1.4 – no clinical cardiovascular disease during the 6 months preceding entry Exclusion Criteria:
- not meet the above criteria – episode of illness (for example: infection) – pregnancy
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Medical University of Warsaw
- Provider of Information About this Clinical Study
- Principal Investigator: Łukasz Czyżewski, Łukasz Czyżewski – Medical University of Warsaw
- Overall Official(s)
- Janusz Wyzgał, Professor, Study Chair, Medical University of Warsaw, Department of Nephrologic Nursing
References
Czyzewski L, Sanko-Resmer J, Wyzgal J, Kurowski A. Comparative analysis of hypertension and its causes among renal replacement therapy patients. Ann Transplant. 2014 Nov 3;19:556-68. doi: 10.12659/AOT.891248.
Czyzewski L, Wyzgal J, Kolek A. Evaluation of selected risk factors of cardiovascular diseases among patients after kidney transplantation, with particular focus on the role of 24-hour automatic blood pressure measurement in the diagnosis of hypertension: an introductory report. Ann Transplant. 2014 Apr 28;19:188-98. doi: 10.12659/AOT.890189.
Czyzewski L, Sanko-Resmer J, Wyzgal J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014 Nov 9;19:576-85. doi: 10.12659/AOT.891265.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.